Jupiter Diagnostics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Liquidation

  • Latest Deal Amount
  • $1.7M

Jupiter Diagnostics General Information

Description

Developer of nano crystal labelled technology designed to deliver high-quality affordable blood testing anywhere for medical diagnostics. The company's services include full scope of blood testing nearer to clinicians and patients and intuitive process that makes collecting blood tests easy, enabling healthcare practitioners to obtain accurate blood tests and thus make faster decisions.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • London BioSciences Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
Primary Industry
Laboratory Services (Healthcare)
Corporate Office
  • London BioSciences Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jupiter Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Bankruptcy: Liquidation 14-Mar-2019 $1.7M Completed Bankruptcy: Liquidation
2. Angel (individual) 01-Apr-2018 Completed Startup
1. Seed Round 05-Apr-2017 $1.96M $1.96M Completed Startup
To view Jupiter Diagnostics’s complete valuation and funding history, request access »

Jupiter Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 6,676,535 $0.013980 $0.06 $0.06 1x $0.06 6.45%
Ordinary 222,642 $0.013980 $0.06 $0.06 1x $0.06 0.22%
To view Jupiter Diagnostics’s complete cap table history, request access »

Jupiter Diagnostics Patents

Jupiter Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2751564-B1 Methods of triggering activation of encapsulated signal-generating substances Active 30-Aug-2011
EP-2751564-A1 Methods of triggering activation of encapsulated signal-generating substances and apparatus utilising activated signal-generating substances Active 30-Aug-2011
ES-2629929-T3 Procedures to trigger the activation of encapsulated signal generating substances Active 30-Aug-2011 G01N33/586

Jupiter Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jupiter Diagnostics FAQs

  • When was Jupiter Diagnostics founded?

    Jupiter Diagnostics was founded in 2015.

  • Where is Jupiter Diagnostics headquartered?

    Jupiter Diagnostics is headquartered in London, United Kingdom.

  • What is the size of Jupiter Diagnostics?

    Jupiter Diagnostics has 8 total employees.

  • What industry is Jupiter Diagnostics in?

    Jupiter Diagnostics’s primary industry is Laboratory Services (Healthcare).

  • Is Jupiter Diagnostics a private or public company?

    Jupiter Diagnostics is a Private company.

  • What is Jupiter Diagnostics’s current revenue?

    The current revenue for Jupiter Diagnostics is .

  • How much funding has Jupiter Diagnostics raised over time?

    Jupiter Diagnostics has raised $2.48M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process